IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 98 filers reported holding IDENIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $556,000 | – | 154,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 29,665,693 | $153,965,000 | 4.40% |
| Bain Capital Public Equity Management, LLC | 12,664,950 | $65,731,000 | 1.65% |
| BRIDGER MANAGEMENT, LLC | 4,360,628 | $22,632,000 | 1.62% |
| 12 West Capital Management LP | 1,782,100 | $9,249,000 | 1.32% |
| GENERAL AMERICAN INVESTORS CO INC | 858,979 | $4,458,000 | 0.39% |
| BB BIOTECH AG | 1,250,000 | $6,488,000 | 0.35% |
| Aris Wealth Services, Inc. | 30,000 | $156,000 | 0.28% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 800,400 | $4,154,000 | 0.16% |
| Visium Asset Management, LP | 1,307,132 | $6,810,000 | 0.15% |
| Old West Investment Management, LLC | 59,038 | $306,000 | 0.15% |